Effects of isoflavones on bone turnover markers in peritoneal dialysis patients: a randomized controlled trial.
Zahra YariHadi TabibiIraj NajafiMehdi HedayatiMina MovahedianPublished in: International urology and nephrology (2020)
This study indicates that daily administration of 100 mg soy isoflavone supplement to PD patients reduces serum N-telopeptide and RANKL which are two bone resorption markers. CLINICALTRIALS.GOV: NCT03773029, 2018.